NCT01696461 2023-09-14
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
Center for International Blood and Marrow Transplant Research
Phase 2 Completed
Center for International Blood and Marrow Transplant Research
Duke University
Washington University School of Medicine
Washington University School of Medicine
Sanofi